adenosine monophosphate has been researched along with Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, S; Hirai, T; Imoto, E; Ito, I; Itohara, K; Kai, S; Katada, Y; Matsumura, K; Nakagawa, T; Ohtsuru, S; Sato, Y; Sukeishi, A; Tanabe, N; Terada, T; Yanagita, M; Yonezawa, A | 1 |
| Cheng, M; Fowler, R; Murthy, S; Pinto, R; Sheehan, NL; Tseng, A | 1 |
| Back, D; Boyle, A; Burger, D; Davidson, K; El-Sherif, O; Gibbons, S; Khoo, S; Marra, F; Marzolini, C; Siccardi, M; Smolders, EJ; Sommerville, AJ | 1 |
| Cowan, PJ; Crikis, S; d'Apice, AJ; Dwyer, KM; Lu, B; Rajakumar, SV; Robson, SC | 1 |
| Coade, SB; Harkness, RA; Webster, AD | 1 |
| Nakamura, S; Nitta, K; Takeo, K | 1 |
1 review(s) available for adenosine monophosphate and Kidney Diseases
| Article | Year |
|---|---|
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Dose-Response Relationship, Drug; Drug Repositioning; Humans; Hydroxychloroquine; Kidney Diseases; Liver Diseases | 2021 |
1 trial(s) available for adenosine monophosphate and Kidney Diseases
| Article | Year |
|---|---|
Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial.
Topics: Adenosine Monophosphate; Alanine; Humans; Kidney; Kidney Diseases | 2022 |
4 other study(ies) available for adenosine monophosphate and Kidney Diseases
| Article | Year |
|---|---|
Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction.
Topics: Adenosine; Adenosine Monophosphate; Aged; Aged, 80 and over; Alanine; Body Surface Area; COVID-19; COVID-19 Drug Treatment; Drug Administration Schedule; Extracorporeal Membrane Oxygenation; Female; Glomerular Filtration Rate; Humans; Japan; Kidney Diseases; Male; Middle Aged; Monte Carlo Method; Precision Medicine; Retrospective Studies | 2022 |
Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Creatinine; Disease Models, Animal; Kidney Diseases; Kidney Function Tests; Mice; Mice, Knockout; Mice, Transgenic; Reperfusion Injury | 2010 |
ATP, ADP and AMP in plasma from peripheral venous blood.
Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Blood Specimen Collection; Chromatography, High Pressure Liquid; Edetic Acid; Hemoglobins; Humans; Kidney Diseases; Lymphocytes; Nucleotidases | 1984 |
Demonstration of phosphorylase in urines by polyacrylamide gel disc electrophoresis.
Topics: Adenosine Monophosphate; Electrophoresis, Disc; Enzyme Activation; Evaluation Studies as Topic; Female; Genital Diseases, Male; Humans; Kidney Diseases; Kinetics; Leukocytes; Male; Mathematics; Methods; Microchemistry; Ovarian Neoplasms; Phosphorylases; Prostatic Diseases; Ultrafiltration; Uterine Neoplasms | 1974 |